Discover 3,059 paid clinical trials in Brockton, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,059
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
for
Metastatic Castration-resistant Prostate Cancer
Location: Newton MA, Boston MA, Lake Success NY, Fairfax VA,
Sponsor: Daiichi Sankyo
Sex: Male
Age: 18+
Code: NCT07244341
Phase 1, Recruiting
Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial
Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
for
Intracranial Meningioma
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: RTOG Foundation, Inc.
Sex: All
Age: 18+
Code: NCT06955169
Phase 2, Recruiting
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07349537
Phase 1, Recruiting
Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes
for
Prostate Cancer, Hot Flashes, Vasomotor Symptoms
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: Male
Age: 18+
Code: NCT07729150
Recruiting
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
for
Chronic Pain, Mental Health Disorders,
Location: Cambridge MA
Sponsor: AugMend Health Inc.
Sex: All
Age: 18+
Code: NCT07336537
Recruiting
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
for
Glioblastoma, GBM
Location: Boston MA, Albany NY, New York NY, Long Island City NY,
Sponsor: Alpheus Medical, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07225621
Phase 2, Recruiting
Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML
for
KMT2A-rearranged, NPM1-mutant Refractory or Relapsed AML
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 12+
Code: NCT07355335
Phase 1, Recruiting
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod